These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 3778712)
21. Role of plasma aluminum in the detection and prevention of aluminum toxicity. Winney RJ; Cowie JF; Robson JS Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005 [No Abstract] [Full Text] [Related]
22. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. Sherrard DJ; Walker JV; Boykin JL Am J Kidney Dis; 1988 Aug; 12(2):126-30. PubMed ID: 3400633 [TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays. Andress DL; Endres DB; Ott SM; Sherrard DJ Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004 [No Abstract] [Full Text] [Related]
24. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO). Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748 [TBL] [Abstract][Full Text] [Related]
25. Effect of aluminum on bone and cell localization. Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993 [No Abstract] [Full Text] [Related]
26. Thrombocytopenia associated with intravenous desferrioxamine. Walker JA; Sherman RA; Eisinger RP Am J Kidney Dis; 1985 Oct; 6(4):254-6. PubMed ID: 4050784 [TBL] [Abstract][Full Text] [Related]
28. Solitary, spontaneous cervical and large bone fractures in aluminum osteodystrophy. Sundaram M; Dessner D; Ballal S Skeletal Radiol; 1991; 20(2):91-4. PubMed ID: 2020868 [TBL] [Abstract][Full Text] [Related]
29. Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia. Barré PE; Prichard S Int J Artif Organs; 1986 May; 9(3):167-72. PubMed ID: 3733242 [TBL] [Abstract][Full Text] [Related]
30. Role of desferrioxamine in the treatment of dialysis encephalopathy. Ackrill P; Ralston AJ; Day JP Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985 [No Abstract] [Full Text] [Related]
31. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease. Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691 [No Abstract] [Full Text] [Related]
32. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy. Felsenfeld AJ ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318 [No Abstract] [Full Text] [Related]
33. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease. Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595 [TBL] [Abstract][Full Text] [Related]
34. [Successful treatment of progressive dialysis encephalopathy. Case report]. Weiland P; Köhler M; Glatzel E Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157 [TBL] [Abstract][Full Text] [Related]
35. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115 [TBL] [Abstract][Full Text] [Related]
36. The use of desferrioximine in dialysis-associated aluminium disease. Ackrill P; Day JP Contrib Nephrol; 1993; 102():125-34. PubMed ID: 8416177 [No Abstract] [Full Text] [Related]
37. Aluminum bone disease. (A case study). Coleman S J Nephrol Nurs; 1985; 2(3):125-6. PubMed ID: 3848476 [No Abstract] [Full Text] [Related]
38. Treatment of dialysis osteomalacia with desferrioxamine. Brown DJ; Dawborn JK; Ham KN; Xipell JM Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756 [TBL] [Abstract][Full Text] [Related]